Multiparametric analysis of preoperative lymphatic mapping with the use of combined deep plus superficial radiotracer injection technique in early breast cancer

Nuclear Medicine Communications

Volumn 29, Issue 6, 2008, Pages 546-552

  Dede, Fuat ^a   Gulluoglu, Bahadir M ^a   Ones, Tunc ^a   Farsakoglu, Zeynep ^a   Calskan, Billur ^a   Mems, Hatice ^a   Erdl, Yusuf T ^a   Inanr, Sabahat ^a   Kaya, Handan ^a   Turoglu, Halil T ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Combined injection technique; Deep injection; Preoperative lymphoscintigraphy; Sentinel lymph node; Superficial injection

Indexed keywords

NANOCOLL TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INJECTION SITE; LYMPH NODE BIOPSY; LYMPHOGRAPHY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJECTIONS, INTRALESIONAL; LYMPHATIC METASTASIS; MIDDLE AGED; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 43149113203     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282f63965     Document Type: Article

References (32)

1. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol 1993; 2:137-143.
2. Engel J, Lebeau A, Sauer H, Hölzel D. Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection. Breast 2006; 15:452-455.
3. Soran A, Falk J, Bonaventura M, Keenan D, Ahrendt G, Johnson R. Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity? J Am Coll Surg 2007; 205:66-71.
4. Pritsivelis C, Garcia Mendonça CA, Pinheiro Pessoa MC, Coelho-Oliveira A, Gutfilen B, Barbosa DA, et al. Failure predictors of the sentinel lymph node in patients with breast cancer using Tc-99m sulfur colloid and periareolar injection. Q J Nucl Med Mol Imaging 2007; 51:189-193.
5. Takei H, Suemasu K, Kurosumi M, Horii Y, Ninomiya J, Kamimura M, et al. Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer 2006; 13:179-185.
6. Goyal A, Newcombe RG, Chhabra A, Mansel RE, ALMANAC Trialists Group. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat 2006; 99:203-208.
7. Chakera AH, Friis E, Hesse U, Al-Suliman N, Zerahn B, Hesse B. Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 2005; 32:286-293.
8. Birdwell RL, Smith KL, Betts BJ, Ikeda DM, Strauss HW, Jeffrey SS. Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Radiology 2001; 220:47-53.
9. Sanli Y, Berberoglu K, Turkmen C, Ozmen V, Muslumanoglu M, Igci A, et al. The value of combined peritumoural and subdermal injection techniques for lymphoscintigraphy in detection of sentinel lymph node in breast cancer. Clin Nucl Med 2006; 31:690-693.
10. Kesmodel SB, Canter RJ, Terhune KP, Bauer TW, Mick R, Rosato EF, et al. Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration. Clin Nucl Med 2006; 31:527-533.
11. Wang HY, Tsai CC, Hung GU, Lin WY. Effectiveness of delayed 2-day lymphoscintigraphy on sentinel lymph node detection in patients with breast cancer with negative early lymphoscintigraphy. Clin Nucl Med 2006; 31:523-526.
12. Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, et al. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med 2005; 30:11-15.
13. van Rijk MC, Tanis PJ, Nieweg OE, Olmos RA, Rutgers EJ, Hoefnagel CA, et al. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol 2006; 94:281-286.
14. Degnim AC, Grant CS. Sentinel lymph node biopsy for breast cancer: is two-site injection best? Surgery 2006; 139:630-632.
15. Zavagno G, Del Bianco P, Koussis H, Artioli G, Carraro P, De Salvo GL, et al. Clinical impact of false-negative sentinel lymph nodes in breast cancer. Eur J Surg Oncol 2007; doi:
16. Koizumi M, Koyama M, Yamashita T, Tada KI, Nishimura SI, Takahashi K, et al. Experience with intradermal injection and intradermal-plus-deep injection in the radioguided sentinel node biopsy of early breast cancer patients. Eur J Oncol 2006; 32:738-742.
17. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al, for the National Surgical Adjuvant Breast and Bowel Project (NSABP). Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8:881-888.
18. Carmon M, Hain D, Shapira J, Golomb E. Preoperative lymphatic mapping does not predict the number of axillary sentinel lymph nodes identified during surgery in breast cancer patients. Breast J 2006; 2:424-427.
19. Morota S, Koizumi M, Koyama M, Sugihara T, Tada KI, Miyagi Y, et al. Radioactivity thresholds for sentinel node biopsy in breast cancer. Eur J Surg Oncol 2006; 32:1101-1104.
20. Newman LA. Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: a comprehensive review of variations in performance and technique. J Am Coll Surg 2004; 199:804-816.
21. Povoski SP, Olsen JO, Young DC, Clarke J, Burak WE, Walker MJ, et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol 2006; 13:1412-1421.
22. Argon AM, Duygun U, Acar E, Daglioz G, Yenjay L, Zekioglu O, et al. The use of periareolar intradermal Tc-99m tin colloid and peritumoural intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node. Clin Nucl Med 2006; 31:795-800.
23. Tanaka C, Fujii H, Ikeda T, Jinno H, Nakahara T, Suzuki T, et al. Stereoscopic scintigraphic imaging of breast cancer sentinel lymph nodes. Breast Cancer 2007; 14:92-99.
24. Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, Aarsvold JN. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe. Semin Nucl Med 2000; 30:56-64.
25. Doting MH, Stiekema HM, de Vries J, Lemstra C, Hoekstra HJ, Vrieling M, et al. Immediate dynamic lymphoscintigraphy delivers no additional value to lymphoscintigraphy 3 h after tracer injection in sentinel lymph node biopsy in breast cancer patients. J Surg Oncol 2007; 95:469-475.
26. Yao MS, Kurland BF, Smith AH, Schubert EK, Dunnwald LK, Byrd DR, et al. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol 2007; 14:2985-2993.
27. Madsen E, Gobardhan P, Bongers V, Albregts M, Burgmans J, De Hooge P, et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol 2007; 14:1486-1492.
28. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006; 56:37-47.
29. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 2005; 35:116-128.
30. Heuts EM, van der Ent FW, van der Pol HA, Debets JM, Kengen RA, Verkeyn JM, et al. Evaluation of early versus delayed lymphoscintigraphic imaging in detecting internal mammary sentinel lymph nodes in breast cancer: a multicenter study to establish an optimal lymphatic mapping protocol. Nucl Med Commun 2006; 27:677-681.
31. de Ferrater MB, Vidal-Sicart S, Zanón G, Martínez-Román S, Sanjuán A, Fernández PL, et al. Importance of intramammary node resection in breast cancer staging. Clin Nucl Med 2007; 32:572-573.
32. Lucci A. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer [Letter]. J Surg Oncol 2006; 94:266-268.